Thomas R. Tice, PhDSenior Director, Global Strategic and Technical Marketing at Evonik Corporation, Health Care
Dr. Tice has 44 years’ experience developing bioabsorbable injectables for long-acting drug delivery. His primary expertise includes long-acting, injectable microparticle formulations, bioabsorbable lactide/glycolide polymers, and microencapsulation and nanoencapsulation processes. He holds 49 US patents with many foreign equivalents and has more than 180 publications, presentations and invited lectures to his credit. He led the team and is one of the inventors that developed the first commercial, injectable, long-acting microparticle product. He has served with United States Pharmacopeia for 18 years, presently serving on the General Chapters-Dosage Forms Expert Committee and several subcommittees including the Nanotechnology Joint Subcommittee and LG Polymer Joint Subcommittee.
Long-Acting Peptide Delivery: Success of Bioabsorbable Microparticle Products and the Future of Bioabsorbable Nanoparticles, 7:45amView Session